Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles

Spokesperson of the Ministry of Commerce answers questions from reporters on the passage of the MATCH Act by the House Committee on Foreign Affairs.

New stock news | Befar Group (601678.SH) submits documents to the Hong Kong Stock Exchange again.

New Stock News | Meike Sheng Energy submitted an application for listing on the Hong Kong Stock Exchange.
Spokesperson of the Ministry of Commerce answers questions from reporters on the passage of the MATCH Act by the House Committee on Foreign Affairs.

New stock news | Befar Group (601678.SH) submits documents to the Hong Kong Stock Exchange again.

New Stock News | Meike Sheng Energy submitted an application for listing on the Hong Kong Stock Exchange.

RECOMMEND

The Great Transformation Of The Hong Kong Automotive Market
23/04/2026

Another “Elephant” Dances As China Construction Bank Hits A Record High While The Sector Remains Below Book Value, With Several Names Offering Elevated Dividend Yields
23/04/2026

Major Oil Traders Warn One Billion Barrel Shortfall Is Locked In, Hormuz Closure Could Trigger Recession
23/04/2026


